Literature DB >> 53217

Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.

J W Lloyd, J A Thomas, M G Mawhinney.   

Abstract

The endogenous concentrations of certain androgens and estrogens have been quantified in the plasma and prostatic tissue from normal dogs and dogs with benign prostatic hypertrophy (BPH). In the tissue and plasma from both dog populations, the level of estrone was higher than that of estradiol. The concentration of testosterone in the tissue and plasma of both normal dogs and dogs exceeded the concentration of either estrogen. Prostatic levels of dihydrotestosterone greatly exceeded that of testosterone. A comparison of normal dogs and dogs with BPH revealed that in both the plasma and prostatic tissue the concentrations of estradiol and estrone were significantly elevated (P less tha 0.05) in the BPH dogs. Plasma and prostatic levels of testosterone did not differ between the two groups; however, the concentration of dihydrotestosterone in hyperplastic glands was approximately 4 times greater than normal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53217

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  3 in total

1.  Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.

Authors:  R J Moore; J M Gazak; J F Quebbeman; J D Wilson
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 2.  Androgen action in prostate function and disease.

Authors:  Partha P Banerjee; Subhadra Banerjee; Terry R Brown; Barry R Zirkin
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

3.  Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.

Authors:  C B Brendler; S J Berry; L L Ewing; A R McCullough; R C Cochran; J D Strandberg; B R Zirkin; D S Coffey; L G Wheaton; M L Hiler; M J Bordy; G D Niswender; W W Scott; P C Walsh
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.